Dr Brigitta Loretz


Brigitta Loretz studied microbiology, did her diploma thesis at the Medical Chemistry and Biochemistry Department and her Ph.D. at the Pharmaceutical Technology Department, University of Innsbruck, Austria.
Her scientific interest is on carriers for intracellular delivery of biopharmaceutics, in particular, nucleotides, for the use in treatment/prevention of infectious diseases, and the development of new excipients, e.g. of new biodegradable polymers for this purpose. Her studies include delivery systems for antiinfectives, antigens or immune modulators as well as cell- or tissue-based models for the design/investigation of (nano)carrier-enabled delivery via non-invasive routes.

This website uses cookies to enhance your user experience. By continuing to browse this website, you are agreeing to our use of cookies. More information